Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ASC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ASC is a gene implicated in neurodegeneration research. Key relationships include: associated with, inhibits, activates. Associated with ALS, Aging, Als. Connected to 255 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | ASC |
| Chromosome | 16p11.2 |
| Protein Type | Gene |
| Function | is a 195-amino acid adaptor protein that serves as a central node in innate immune signaling. |
| Primary Expression | microglia, astrocytes, and certain neurons, where it drives neuroinflammation and contributes to the pathogenesis of Alzheimer's disease, Parkinson's |
| Molecular Weight | 22 kDa |
| Pathways | Apoptosis, Inflammasome, Innate Immunity, Pyroptosis |
| UniProt ID | Q9Y258 |
| NCBI Gene ID | 29108 |
| GeneCards | ASC |
| Human Protein Atlas | ASC |
| Phosphorylation | TBK1 phosphorylates ASC at Ser194, enhancing its ability to form specks and amplifying innate immune responses[@hara2013] |
| Ubiquitination | K63-linked ubiquitination of ASC regulates its stability and inflammasome activity |
| SUMOylation | SUMO modification at specific lysine residues modulates ASC function |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease, Atherosclerosis |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACTB, Actin, AGING, AIF1, AIM2, AKT |
| KG Connections | 924 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
ASC["ASC"] -.->|"inhibits"| Neurodegeneration["Neurodegeneration"]
ASC["ASC"] -.->|"inhibits"| Inflammation["Inflammation"]
ASC["ASC"] -.->|"inhibits"| Als["Als"]
ASC["ASC"] -.->|"inhibits"| Aging["Aging"]
ASC["ASC"] -->|"regulates"| Tumor["Tumor"]
ASC["ASC"] -->|"regulates"| Parkinson["Parkinson"]
NLRP3["NLRP3"] -->|"activates"| ASC["ASC"]
ACTB["ACTB"] -.->|"inhibits"| ASC["ASC"]
IL1B["IL1B"] -->|"regulates"| ASC["ASC"]
IL6["IL6"] -->|"regulates"| ASC["ASC"]
style ASC fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Inflammation | activates | disease | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| apoptosis pathway | participates_in | pathway | 0.90 |
| MICROGLIA | expressed_in | cell_type | 0.90 |
| ASTROCYTES | expressed_in | cell_type | 0.90 |
| pyroptosis | participates_in | pathway | 0.90 |
| oxidative stress response | participates_in | pathway | 0.90 |
| microglia | expressed_in | cell_type | 0.90 |
| NLRP3 | interacts_with | entity | 0.90 |
| Inflammasome | associated_with | pathway | 0.85 |
| Tumor | associated_with | disease | 0.85 |
| ALZHEIMER'S DISEASE | involved_in | disease | 0.85 |
| Aβ plaques | associated_with | biological_process | 0.80 |
| microglia | associated_with | cell_type | 0.80 |
| autism spectrum disorder | interacts_with | disease | 0.80 |
| inflammasome | modulates | biological_process | 0.80 |
| microglia | activates | cell_type | 0.80 |
| ubiquitin-proteasome | participates_in | pathway | 0.80 |
| autophagy pathway | participates_in | pathway | 0.80 |
| Inflammasome | inhibits | pathway | 0.80 |
| Autophagy | inhibits | pathway | 0.80 |
| PYCARD | associated_with | gene | 0.80 |
| NLRP3 | associated_with | gene | 0.80 |
| TNF | associated_with | gene | 0.80 |
| Als | inhibits | disease | 0.75 |
| Inflammation | inhibits | disease | 0.75 |
| Alzheimer | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| NLRP3 | biomarker_for | gene | 0.70 |
| PYCARD | activates | gene | 0.70 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| ULK1 | associated_with | gene | 0.70 |
| MICROGLIA | activates | gene | 0.70 |
| UBIQUITIN | regulates | gene | 0.70 |
| LC3 | associated_with | gene | 0.70 |
| substantia nigra | expressed_in | brain_region | 0.70 |
| AIM2 | associated_with | gene | 0.70 |
| LAMP1 | associated_with | gene | 0.70 |
| unfolded protein response | participates_in | pathway | 0.70 |
| pyroptosis | activates | process | 0.70 |
| Alzheimer's disease | expressed_in | disease | 0.70 |
| Alzheimer's disease | activates | disease | 0.70 |
| Alzheimer's disease | regulates | disease | 0.70 |
| hippocampus | expressed_in | brain_region | 0.70 |
| ALZHEIMER'S DISEASE | activates | gene | 0.70 |
| macrophages | expressed_in | cell_type | 0.70 |
| IL1B | associated_with | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| Parkinson's disease | regulates | disease | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NLRP3 | activates | protein | 1.00 |
| NLRP3 | interacts_with | protein | 0.90 |
| P62 | associated_with | gene | 0.70 |
| NLRP3 | regulates | gene | 0.70 |
| TNF | regulates | gene | 0.70 |
| rapamycin | targets | drug | 0.70 |
| AUTOPHAGY | inhibits | gene | 0.70 |
| APOPTOSIS | associated_with | gene | 0.60 |
| PYROPTOSIS | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| APP/PS1 | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AMPK | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| Β-HYDROXYBUTYRATE | inhibits | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| TNF-ALPHA | regulates | gene | 0.60 |
| GFP | inhibits | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| AQP3 | activates | gene | 0.60 |
| MAPK | expressed_in | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| AQP5 | activates | gene | 0.60 |
| HO-1 | expressed_in | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | contributes_to | gene | 0.60 |
| ALS | contributes_to | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | contributes_to | gene | 0.60 |
| NLR | regulates | gene | 0.60 |
| MITOCHONDRIA | expressed_in | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| IL-1 | associated_with | gene | 0.60 |
| NLR | associated_with | gene | 0.60 |
| STROKE | contributes_to | gene | 0.60 |
| IL-1 | therapeutic_target | gene | 0.60 |
| IL-4 | therapeutic_target | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| IL-1 | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| IL-18 | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| GASDERMIN | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.732
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Anti-ASC antibody intracerebroventricular injection in APP/PS1 mice | validation | Alzheimer's disease | 0.950 | 0.00 | APP/PS1 transgenic mice (8 mon | proposed | N/A |
| Mobile App-Based Intervention for BPSD in Community-Dwelling Dementia | clinical | dementia with behavioral and p | 0.950 | 0.00 | human patients | proposed | N/A |
| Plasma ATN biomarkers across AD continuum in Chilean cohort | clinical | Alzheimer's disease | 0.950 | 0.00 | Chilean older adults (n=318) w | proposed | N/A |
| ASC antibody treatment in SH-SY5Y-APP695 cells | exploratory | Alzheimer's disease | 0.900 | 0.00 | SH-SY5Y-APP695 cells | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Differential GWAS of schizophrenia vs PTSD | exploratory | schizophrenia, post-traumatic | 0.900 | 0.00 | human patients - European ance | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Creation and validation of 3xAD-ChAT-Cre mouse model | validation | Alzheimer's disease | 0.900 | 0.00 | 3xAD-ChAT-Cre transgenic mice | proposed | N/A |
| Single-cell RNA sequencing analysis of human atherosclerotic plaques | exploratory | Atherosclerosis | 0.900 | 0.00 | Human atherosclerotic plaque s | proposed | N/A |
| GTEx brain tissue expression analysis of MAPT/CRHR1 locus | exploratory | schizophrenia, post-traumatic | 0.850 | 0.00 | human brain tissue samples fro | proposed | N/A |
| Microtubule domain analysis in adult axons | exploratory | 0.800 | 0.00 | adult rodent axons | proposed | N/A | |
| Tau depletion effects on microtubule domains in adult axons | exploratory | 0.800 | 0.00 | adult rodent neurons | proposed | N/A | |
| Proposed experiment from debate on Synaptic pruning by microglia in ea | falsification | Alzheimer's Disease | 0.400 | 0.50 | mouse | proposed | $200,000 |
| Proposed experiment from debate on Senolytics targeting p16/p21+ senes | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe | clinical | Neurodegeneration | 0.400 | 0.50 | in_silico | proposed | $180,000 |
| Mechanism: Why Does Amyloid Removal Only Slow Decline 27%? | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,500,000 |
| Experiment: Autoimmune Hypothesis Testing in AD | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated Neurotoxic | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| cGAS-STING Pathway Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| Microglial Aging and Immune Memory in Neurodegeneration — Training the | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $2,960,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Complement, Inflammasome, and Microglial Crosstalk in Glaucoma: From Neurodegene [PMID:41900887] | Chen TY, Wu N, Sun X | Life (Basel) | 2026 | 1 |
| Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteost [PMID:40868276] | Voicu V, Toader C, Șerban M, Covache-Bus | Biomedicines | 2025 | 1 |
| Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] | Han QQ, Shen SY, Liang LF, Chen XR, Yu J | Brain Behav Immun | 2024 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Microglia regulation of synaptic plasticity and learning and memory. [PMID:34472455] | Cornell J, Salinas S, Huang HY, Zhou M | Neural Regen Res | 2022 | 1 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| Complement and microglia mediate early synapse loss in Alzheimer mouse models. [PMID:27033548] | Hong S, Beja-Glasser VF, Nfonoyim BM, Fr | Science | 2016 | 1 |
| Panacis Quinquefolii Radix Polysaccharides Alleviate Depressive-Like Behaviors i [PMID:41914021] | Xie M, Feng L, Li R, Li M, Shen L, Zhang | CNS neuroscience & therapeutic | 2026 | 0 |
| Vaccine-induced antibodies can limit Salmonella infection in the absence of comp [PMID:41738756] | Perez-Toledo M, Aksu-Istil K, Marcial-Ju | mBio | 2026 | 0 |
| The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436] | Gopalakrishna PK, Che Mohd Nassir CMN, A | Cellular and molecular neurobi | 2026 | 0 |
| Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-C [PMID:41766448] | Taxiarchis A, Pruner I | Current opinion in hematology | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974] | Dai L, Wang J, Meng L, Zhang X, Xiao T, | PLoS biology | 2025 | 0 |
| PDE4 inhibition alleviates HMGB1/C1q/C3-mediated excessive phagocytic pruning of [PMID:39947489] | Zhao Q, Zeng C, Luo F, Xian Z, Wen H, Tu | Brain, behavior, and immunity | 2025 | 0 |
| Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Thera [PMID:40922457] | ["Eroglu E", "Harmanci N"] | Basic & clinical pharmacology | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Chrysophanol Attenuates Cognitive Impairment, Neuroinflammation, and Oxidative S [PMID:40728692] | Khan JZ, Zainab SR, Alattar A | Neurochem Res | 2025 | 0 |
| Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR [PMID:38184025] | Unknown | Journal of ethnopharmacology | 2024 | 0 |
| Botulinum Neurotoxin Induces Neurotoxic Microglia Mediated by Exogenous Inflamma [PMID:38342616] | Ambrin G, Kang YJ, Van Do K, Lee C, Sing | Advanced science (Weinheim, Ba | 2024 | 0 |
| Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric [PMID:38456789] | ["Zhu J", "Wei R", "Hu G", "Wang H", "Wa | Small (Weinheim an der Bergstr | 2024 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.69 · 2026-04-12
closed · Rounds: 7 · Score: 0.91 · 2026-04-10
closed · Rounds: 4 · Score: 0.95 · 2026-04-01
Hypotheses and analyses mentioning ASC in their description or question text
Score: 0.812 · neuroscience · 2026-04-12
## Mechanistic Overview TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance starts from the claim
Score: 0.772 · neurodegeneration · 2026-04-21
## Mechanistic Overview TBK1-OPTN-NDP52 Phospho-Cascade Coordinates Multi-Organelle Autophagy starts from the claim that
Score: 0.760 · neurodegeneration · 2026-04-25
NAC serves as a GSH precursor and direct antioxidant to inhibit ferroptosis in cerebral microvascular endothelial cells
Score: 0.754 · neuroscience · 2026-04-07
## Mechanistic Overview Dual-Circuit Tau Vulnerability Cascade starts from the claim that modulating MAPT within the dis
Score: 0.741 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The complement-SASP amplification cascade represents a mechanistic nexus where ce
Score: 0.720 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The complement cascade represents a critical innate immune system that, when dysr
Score: 0.718 · neurodegeneration · 2026-04-02
## Mechanistic Overview Retinal Vascular Microcirculation Rescue starts from the claim that modulating PDGFRB/ANGPT1 wit
Score: 0.696 · neuroscience · 2026-04-07
## **Molecular Mechanism and Rationale** The dual-circuit tau vulnerability cascade with glial-mediated amplification r
Score: 0.690 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of the brain
Score: 0.678 · neurodegeneration · 2026-04-26
TDP-43 aggregates sequester hepatocyte growth factor-regulated tyrosine kinase substrate (HGS), a critical hub coordinat
Score: 0.670 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents the most abundant water channel i
Score: 0.666 · neuroscience · 2026-04-07
## Mechanistic Overview Glymphatic-Cholinergic Tau Clearance Cascade starts from the claim that modulating MAPT within t
Score: 0.662 · unknown disease · 2026-04-26
CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau path
Score: 0.650 · neurodegeneration · 2026-04-21
## **Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of the br
Score: 0.648 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The OPTN/TBK1 phosphorylation cascade represents a critical quality control mecha